» Articles » PMID: 29740434

Lack of Evidence for a Direct Interaction of Progranulin and Tumor Necrosis Factor Receptor-1 and Tumor Necrosis Factor Receptor-2 From Cellular Binding Studies

Overview
Journal Front Immunol
Date 2018 May 10
PMID 29740434
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Progranulin (PGRN) is a secreted anti-inflammatory protein which can be processed by neutrophil proteases to various granulins. It has been reported that at least a significant portion of the anti-inflammatory effects of PGRN is due to direct high affinity binding to tumor necrosis factor receptor-1 (TNFR1) and TNFR2 and inhibition of tumor necrosis factor (TNF)-induced TNFR1/2 signaling. Two studies failed to reproduce the interaction of TNFR1 and TNFR2 with PGRN, but follow up reports speculated that this was due to varying experimental circumstances and/or the use of PGRN from different sources. However, even under consideration of these speculations, there is still a striking discrepancy in the literature between the concentrations of PGRN needed to inhibit TNF signaling and the concentrations required to block TNF binding to TNFR1 and TNFR2. While signaling events induced by 0.2-2 nM of TNF have been efficiently inhibited by low, near to equimolar concentrations (0.5-2.5 nM) of PGRN in various studies, the reported inhibitory effects of PGRN on TNF-binding to TNFR1/2 required a huge excess of PGRN (100-1,000-fold). Therefore, we investigated the effect of PGRN on TNF binding to TNFR1 and TNFR2 in highly sensitive cellular binding studies. Unlabeled TNF inhibited >95% of the specific binding of a luciferase (GpL) fusion protein of TNF to TNFR1 and TNFR2 and blocked binding of soluble GpL fusion proteins of TNFR1 and TNFR2 to membrane TNF expressing cells to >95%, too. Purified PGRN, however, showed in both assays no effect on TNF-TNFR1/2 interaction even when applied in huge excess. To rule out that tags and purification- or storage-related effects compromise the potential ability of PGRN to bind TNF receptors, we directly co-expressed PGRN, and as control TNF, in TNFR1- and TNFR2-expressing cells and looked for binding of GpL-TNF. While expression of TNF strongly inhibited binding of GpL-TNF to TNFR1/2, co-expression of PGRN had not effect on the ability of the TNFR1/2-expressing cells to bind TNF.

Citing Articles

Granulins rescue inflammation, lysosome dysfunction, lipofuscin, and neuropathology in a mouse model of progranulin deficiency.

Root J, Mendsaikhan A, Taylor G, Merino P, Nandy S, Wang M Cell Rep. 2024; 43(12):114985.

PMID: 39565694 PMC: 11773623. DOI: 10.1016/j.celrep.2024.114985.


Analysis of intracellular communication reveals consistent gene changes associated with early-stage acne skin.

Deng M, Odhiambo W, Qin M, To T, Brewer G, Kheshvadjian A Cell Commun Signal. 2024; 22(1):400.

PMID: 39143467 PMC: 11325718. DOI: 10.1186/s12964-024-01725-4.


Analysis of Intracellular Communication Reveals Consistent Gene Changes Associated with Early-Stage Acne Skin.

Deng M, Odhiambo W, Qin M, To T, Brewer G, Kheshvadjian A Res Sq. 2024; .

PMID: 38854033 PMC: 11160929. DOI: 10.21203/rs.3.rs-4402048/v1.


Progranulin and GPNMB: interactions in endo-lysosome function and inflammation in neurodegenerative disease.

Gillett D, Wallings R, Uriarte Huarte O, Tansey M J Neuroinflammation. 2023; 20(1):286.

PMID: 38037070 PMC: 10688479. DOI: 10.1186/s12974-023-02965-w.


Progranulinopathy: A diverse realm of disorders linked to progranulin imbalances.

Huang G, Jian J, Liu C Cytokine Growth Factor Rev. 2023; 76:142-159.

PMID: 37981505 PMC: 10978308. DOI: 10.1016/j.cytogfr.2023.11.001.


References
1.
Tsujimoto M, Yip Y, Vilcek J . Tumor necrosis factor: specific binding and internalization in sensitive and resistant cells. Proc Natl Acad Sci U S A. 1985; 82(22):7626-30. PMC: 391386. DOI: 10.1073/pnas.82.22.7626. View

2.
Niitsu Y, Watanabe N, Sone H, Neda H, Yamauchi N, Maeda M . Analysis of the TNF receptor on KYM cells by binding assay and affinity cross-linking. J Biol Response Mod. 1988; 7(3):276-82. View

3.
Stubert J, Waldmann K, Dieterich M, Richter D, Briese V . Progranulin shows cytoprotective effects on trophoblast cells in vitro but does not antagonize TNF-α-induced apoptosis. Arch Gynecol Obstet. 2014; 290(5):867-73. DOI: 10.1007/s00404-014-3296-3. View

4.
Yamamoto Y, Takemura M, Serrero G, Hayashi J, Yue B, Tsuboi A . Increased serum GP88 (Progranulin) concentrations in rheumatoid arthritis. Inflammation. 2014; 37(5):1806-13. DOI: 10.1007/s10753-014-9911-4. View

5.
Pennica D, Lam V, WEBER R, Kohr W, Basa L, Spellman M . Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor. Biochemistry. 1993; 32(12):3131-8. DOI: 10.1021/bi00063a027. View